Surmodics, Inc. announced the early clinical use of its Pounce XL thrombectomy system, which is currently in limited market rel ...
Auxilium Biotechnologies successfully deployed its 3D bioprinter on ISS & printed 8 implantable medical devices that repair ...
Surmodics (Nasdaq:SRDX) today announced the successful early clinical use of its Pounce XL thrombectomy system.
Instylla's Tembo system is a bioresorbable embolization agent designed for embolization of hypervascular tumors and blood ...
Research led by Lancaster University has revealed clear evidence that changes in the orchestration of brain oxygenation ...
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...
Learn more about whether Bausch + Lomb Corporation or LeMaitre Vascular, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Instylla, Inc., a developer of solutions for peripheral vascular embolotherapy, announced the FDA 510(k) clearance of the ...
In a bid to revolutionize Alzheimer’s detection, scientists have examined the brain’s neurovascular unit. The research ...